KOSDAQ-listed Acryl Targets Global Market with End-to-End Integrated AX Platform
Acryl, a leader in the era of AI transformation, made a splendid debut on KOSDAQ and commenced official trading. Since its establishment in 2011, Acryl has dedicated itself solely to AI. Spearheading with its self-developed integrated AX pl...
Acryl, a leader in the era of AI transformation, made a splendid debut on KOSDAQ and commenced official trading. Since its establishment in 2011, Acryl has dedicated itself solely to AI. Spearheading with its self-developed integrated AX platform, ‘Jonathan’, and by being recognized for its 'End-to-End' technological prowess, encompassing the entire process of AI implementation from data preprocessing to model training, deployment, and operation (MLOps), it achieved the honor of a technology special listing.
Notably, Acryl's true value shines in the medical field. Through close collaboration with major domestic tertiary hospitals such as Samsung Medical Center, Seoul St. Mary's Hospital, and Yonsei University Health System, it has developed innovative medical AI software and possesses a robust product lineup that has obtained product approval from the Ministry of Food and Drug Safety. Based on this, it is leading the future medical paradigm by preempting the 'intelligent hospital' infrastructure market, which supports everything from early diagnosis to prognosis management.
The unique technological capability to maximize the utilization of expensive GPU resources is another of Acryl's strengths. The GPU virtualization and operation optimization technology integrated into the ‘Jonathan’ platform dramatically reduces enterprise infrastructure construction costs and maximizes AI operational efficiency.
The public offering funds secured through this listing will lead to bold investments in Acryl's future. The company plans to further strengthen its global competitiveness through the advancement of next-generation large language model (LLM)-based AX infrastructure, as well as by entering the global healthcare market and securing AI specialized talent.
CEO Park Woiejin expressed pride in the 14 years spent building technological capabilities with the goal of 'AX solutions that anyone can easily use', and stated the ambition to leverage the listing as an opportunity to enhance shareholder value through continuous technological innovation and leap forward as a company that leads the global AX infrastructure market in every sense of the word. Acryl's KOSDAQ listing is not merely corporate growth, but an expression of a strong will to open new horizons in the era of AI transformation.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0